Acumen Pharmaceuticals Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.30

+0.06 (+2.68%)

As of Sep 28, 10:19 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +866.1% upside

Low Target $18.81

Average Target $22.22

High Target $35.10

Current Price $2.30

Current
$2.30

Target
$22.22

$18.81 $22.22 avg $35.10

Scenario Analysis

Bear Case

$18.81

717.8%

Low target

Base Case

$22.22

+866.1%

Avg target

Bull Case

$35.10

+1,426.1%

High target

Risk/Reward

2.0x

Balanced

Price in Context

52-Week High

$3.60

-36.1% from high

52-Week Low

$1.22

+88.5% from low

Target vs 52W High

$22.22

+517.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.2%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.9%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.7%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-26.5%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.5%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-44.2%